India In-Vitro Diagnostics Industry Analysis till 2018 - Accreditation and Automation to Drive Future Growth
Market Overview
Growth Drivers
Constraints
Regulatory Framework and Accreditation
2. INDIA IN-VITRO DIAGNOSTICS MARKET SIZE BY REVENUES, FY’2007-FY’2013
3. INDIA IN-VITRO DIAGNOSTICS MARKET SEGMENTATION
3.1. By Reagents and Instruments, FY’2010-FY’2013
3.2. By Urban and Rural Areas, FY’2013
3.3. By Type of Tests, FY’2007-FY’2013
4. INDIA IMMUNOCHEMISTRY MARKET
4.1. Market Scenario
Market Overview
Drivers
Constraints
Emerging Technology Trends
4.2. India Immunochemistry Market Size, FY’2007- FY’2013
4.3. India Immunochemistry Market Segmentation Reagents and Instruments, ELISA Kits and Rapid Tests, FY’2007-FY’2013
4.3.1. India Immunochemistry Instruments and Reagents Market Size, FY’2007-FY’2013
4.3.2. India Immunochemistry Instruments and Reagents Market Segmentation By Type of Tests, FY’2007-FY’2013
4.3.3. India Immunochemistry Reagents Market Segmentation by End Use, FY’2007-FY’2013
4.4. Market Share of Major Players in India Immunochemistry Market, FY’2013
5. INDIA BIOCHEMISTRY MARKET
5.1. Market Scenario
Market Overview
Growth Drivers
Constraints
Trends
5.2. India Biochemistry Market Size, FY’2007 – FY’2013
5.3. India Biochemistry Market Segmentation by Reagents and Instruments, FY’2007-FY’2013
5.4. Market Share of Major Players in India Biochemistry Market, FY’2013
6. INDIA HEMATOLOGY MARKET
6.1. Market Scenario
Market Overview
Growth Drivers
Constraints
Trends
6.2. India Hematology Market Size, FY’2007-FY’2013
6.3. India Hematology Market Segmentation By Reagents and Instruments, FY’2007-FY’2013
6.4. India Hematology Market Competitive Landscape
7. INDIA MICROBIOLOGY MARKET
7.1. Market Scenario
Market Overview
Growth Drivers
Constraints
Trends
7.2. India Microbiology Market Size, FY’2007-FY’2013
7.3. India Microbiology Market Segmentation by Reagents and Instruments, FY’2008-FY’2013
7.4. Market Share of Major Players in India Microbiology Market, FY’2013
8. INDIA BLOOD GAS AND ELECTROLYTE MARKET
8.1. Market Scenario
Market Overview
Growth Drivers
Constraints
Trends
8.2. India Blood Gas and Electrolyte Market Size, FY’2007 - FY’2013
8.3. India Blood Gas and Electrolyte Market Segmentation by Reagents and Instruments, FY’2007-FY’2013
8.4. Market Share of Major Players in India Blood Gas and Electrolyte Market, FY’2013
9. INDIA MOLECULAR DIAGNOSTICS MARKET
9.1. Market Scenario
Market Overview
Growth Drivers
Constraints
Trends
9.2. India Molecular Diagnostics Market Size, FY’2007 - FY’2013
9.3. India Molecular Diagnostics Market Segmentation by Reagents and Instruments, FY’2007-FY’2013
10. INDIA URINALYSIS MARKET
10.1. Market Scenario
Market Overview
Growth Drivers
Constraints
Trends
10.2. India Urinalysis Market Size, FY’2007 - FY’2013
10.3. India Urinalysis Market Segmentation by Reagents and Instruments, FY’2007-FY’2013
11. INDIA COAGULATION DIAGNOSTICS MARKET
11.1. Market Scenario
Market Overview
Growth Drivers
Constraints
Trends
11.2. India Coagulation Diagnostics Market Size, FY’2007 – FY’2013
11.3. India Coagulation Diagnostics Market Segmentation by Reagents and Instruments, FY’2007-FY’2013
12. INDIA IN-VITRO DIAGNOSTICS MARKET TRENDS AND DEVELOPMENTS
Mounting Demand for Decentralized Laboratory Tests
Increasing Penetration in Rural Areas
Early Detection as an Emerging Trend
Inclining Automation of Labs
Increasing Consolidation
Increasing Overseas Expansion
Inclining Prevalence of Hospital Laboratory Management (HLM)
13. MARKET SHARE OF MAJOR PLAYERS IN INDIA IN-VITRO DIAGNOSTICS MARKET, FY’2013
14. COMPANY PROFILES OF MAJOR PLAYERS IN INDIA IN-VITRO DIAGNOSTICS MARKET
15. INDIA IN-VITRO DIAGNOSTICS MARKET FUTURE OUTLOOK AND PROJECTIONS, FY’2014-FY’2018
15.1. Cause and Effect Relationship Analysis of the In-vitro Diagnostics Market in India
16. MACROECONOMIC AND INDUSTRY FACTORS: HISTORICAL AND PROJECTIONS
16.1. Population in India, FY’2007-FY’2018
16.2. Personal Disposable Income in India, FY’2007-FY’2018
16.3. Consumer Expenditure on Healthcare in India, FY’2007-FY’2018
16.4. Government Expenditure on Healthcare in India, FY’2007-FY’2018
16.5. Foreign Direct Investments in Healthcare, FY’2008-FY’2013
16.6. Private Equity Investments in Healthcare, 2009-2012
17. APPENDIX
17.1. Market Definitions
17.2. Abbreviations
17.3. Research Methodology
Data Collection Methods
Approach
Variables (Dependent and Independent)
Final Conclusion
17.4. Disclaimer
Figure 1: India In-Vitro Diagnostics Market Size on the Basis of Revenues in USD Million, FY’2007-FY’2013
Figure 2: India In-Vitro Diagnostics Market Segmentation on the Basis of Revenues from Instruments and Reagents in Percentage, FY’2010-FY’2013
Figure 3: India In-Vitro Diagnostics Market Segmentation on the Basis of Revenues from Urban and Rural Areas in Percentage, FY’2013
Figure 4: India In-Vitro Diagnostics Market Segmentation on the Basis of Revenues from Different Tests in Percentage, FY’2007-FY’2013
Figure 5: India Immunochemistry Market Size on the Basis of Revenues in USD Million, FY’2007-FY’2013
Figure 6: India Immunochemistry Market Segmentation on the Basis of Revenues from Reagents and Instruments, ELISA Kits and Rapid Tests in Percentage, FY’2007-FY’2013
Figure 7: India Immunochemistry Instruments and Reagents Market Size on the Basis of Revenues in USD Million, FY’2007-FY’2013
Figure 8: India Immunochemistry Instruments and Reagents Market Segmentation on the Basis of Revenues from Instruments and Reagents in Percentage, FY’2007-FY’2013
Figure 9: India Immunochemistry Instruments and Reagents Market Segmentation on the Basis of Revenues from Different Types of Instruments and Reagents in Percentage, FY’2007-FY’2013
Figure 10: India Immunochemistry Reagents Market Segmentation on the Basis of Revenues from End Use in Different Types of Diagnostic Tests in Percentage, FY’2007-FY’2013
Figure 11: India Biochemistry Market Size on the Basis of Revenues in USD Million, FY’2007-FY’2013
Figure 12: India Biochemistry Market Segmentation on the Basis of Revenues from Reagents and Instruments in Percentage, FY’2007-FY’2013
Figure 13: India Biochemistry Instruments Market Segmentation on the Basis of Revenues from Different Types of Analyzers in Percentage, FY’2011-FY’2013
Figure 14: Market Share of Major Players on the Basis of Revenues in the Biochemistry Market in India in Percentage, FY’2013
Figure 15: India Hematology Market Size on the Basis of Revenues in USD Million, FY’2007-FY’2013
Figure 16: India Hematology Market Segmentation on the Basis of Revenues from Reagents and Instruments in Percentage, FY’2007-FY’2013
Figure 17: India Hematology Instruments Market Segmentation on the Basis of Revenues from Different Type of Instruments in Percentage, FY’2009-FY’2012
Figure 18: India Microbiology Market Size on the Basis of Revenues in USD Million, FY’2007-FY’2013
Figure 19: India Microbiology Market Segmentation on the Basis of Revenues from Reagents and Instruments in Percentage, FY’2008-FY’2013
Figure 20: India Blood Gas and Electrolyte Market Size on the Basis of Revenues in USD Million, FY’2007-FY’2013
Figure 21: India Blood Gas and Electrolyte Market Segmentation on the Basis of Revenues from Reagents and Analyzers in Percentage, FY’2007-FY’2013
Figure 22: India Blood Gas and Electrolyte Analyzers Market Segmentation on the Basis of Revenues from Different Types of Analyzers in Percentage, FY’2009-FY’2013
Figure 23: Market Share of Major Players on the Basis of Revenues in the Blood Gas and Electrolyte Market in Percentage, FY’2013
Figure 24: India Molecular Diagnostics Market Size on the Basis of Revenues in USD Million, FY’2007-FY2013
Figure 25: India Molecular Diagnostics Market Segmentation on the Basis of Revenues from Reagents and Instruments in Percentage, FY’2007-FY’2013
Figure 26: India Urinalysis Market Size on the Basis of Revenues in USD Million, FY’2007-FY’2013
Figure 27: India Urinalysis Market Segmentation on the Basis of Revenues from Reagents and Instruments in Percentage, FY’2007-FY’2013
Figure 28: India Coagulation Diagnostics Market Size on the Basis of Revenues in USD Million, FY’2007-FY’2013
Figure 29: India Coagulation Diagnostics Market Segmentation on the Basis of Revenues from Reagents and Instruments in Percentage, FY’2007-FY’2013
Figure 30: Market Share of Major Players on the Basis of Revenues in the India In-Vitro Diagnostics Market in Percentage, FY’2013
Figure 31: India In-Vitro Diagnostics Market Future Projections on the Basis of Revenues in USD Million, FY’2014-FY’2018
Figure 32: Population in India in Million, FY’2007-FY’2018
Figure 33: Personal Disposable Incomes in India in USD Million, FY’2007-FY’2018
Figure 34: Consumer Expenditure on Healthcare and Medical Services in India in USD Million, FY’2007-FY’2018
Figure 35: Government Expenditure on Health Care in India in USD Million, FY’2007-FY’2018
Figure 36: Foreign Direct Investment in Healthcare Sector in India in USD Million, FY’2008-FY’2013
Figure 37: Private Equity Investments in Healthcare Sector in India in USD Million, 2009-2012
The report titled “India In-Vitro Diagnostics Industry Analysis till 2018 – Accreditation and Automation to Drive Future Growth” provides a comprehensive analysis of the various aspects such as market size of the India in-vitro diagnostics market, India immunochemistry market, India biochemistry market, India hematology market, India microbiology market, India blood gas and electrolyte market, India molecular diagnostics market, India urinalysis market and India coagulation market. The report also covers the market shares of major players in the immunochemistry, biochemistry and microbiology space as well as the overall in-vitro diagnostics market in India.
In-vitro diagnostics market in India, which has hugely been driven by the increasing number of lifestyle diseases, inclining preventive healthcare practices, mounting disposable incomes, government’s initiatives and improving healthcare infrastructure, registered revenues of USD ~ million in FY’2013. With the advent of new varieties of diagnostic tests incorporating latest technology, the revenues increased by 25.8% compared to FY’2012, where the total revenues were USD ~ million. In-vitro diagnostics market in India is subject to a gamut of different factors, such as people with diabetes, heart, kidney and other infectious and lifestyle diseases, and the overall disposable incomes in the country, which play an important role in determining the revenues from various diagnostic segments. Immunochemistry was the largest contributing category in terms of revenue, having recorded sales of USD ~ million in fiscal year 2013, while biochemistry, hematology and microbiology also contributed a significant share to the overall revenues. The India in-vitro diagnostics market has grown at a CAGR of 19.4% from USD 303.2 million in FY’2007 to USD ~ million in FY’2013.
The in-vitro diagnostics market in India is comprised of various manufacturers that specialize in the development and production of diagnostic products in different segments. Along with the presence of leading diagnostic companies in the organized sector, market in India is also driven by the revenues of a huge number of manufacturers in the unorganized segment. Roche was the market leader in the overall IVD market India, while also dominating the immunochemistry and biochemistry segments in fiscal year 2013. In addition to the prevalence of several players in the organized segment, the market is also driven by the imports of numerous diagnostic products from China and other countries
In-vitro diagnostics market in India has showcased several emerging trends over the past few years. Some of the most definitive of these trends has been the advent of decentralized testing, mounting automation in laboratories, increasing consolidation and preference for early detection of diseases. Several pathological labs have resorted to invest heftily, and have been adopting fully automated systems for diseases diagnosis. In light of this, the accuracy of test results has increased, while the turnaround times have declined significantly. Additionally, the growth of portable diagnostics devices has propelled the market for point of care testing in India.
The market for in-vitro diagnostics in India is changing at a brisk rate. Technological advancements, demand of diagnostic tests from an ever growing base of disease-ridden population, and people suffering from lifestyle diseases, as well as the transition of diagnostic product manufacturers from the unorganized to the organized segment have been significantly changing the market. Revenues from the in-vitro diagnostics market in India are expected to expand to USD ~ million in FY’2018, growing with a CAGR of ~% from FY’2013 to FY’2018.
